Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 273,264
  • Shares Outstanding, K 287,858
  • Annual Sales, $ 6,040 K
  • Annual Income, $ -63,080 K
  • EBIT $ -58 M
  • EBITDA $ -57 M
  • 60-Month Beta 3.75
  • Price/Sales 43.45
  • Price/Cash Flow N/A
  • Price/Book 13.85
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings $-0.04 on 08/08/24
  • Next Earnings Date 11/08/24 [BMO]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 129.31% ( -17.73%)
  • Historical Volatility 57.78%
  • IV Percentile 37%
  • IV Rank 5.64%
  • IV High 1,030.35% on 11/09/23
  • IV Low 75.50% on 02/07/24
  • Put/Call Vol Ratio 0.11
  • Today's Volume 1,171
  • Volume Avg (30-Day) 1,283
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 65,864
  • Open Int (30-Day) 60,246

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.05
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8900 +7.58%
on 10/24/24
1.0400 -7.93%
on 10/29/24
-0.0525 (-5.20%)
since 10/04/24
3-Month
0.8900 +7.58%
on 10/24/24
1.4000 -31.61%
on 08/26/24
-0.2675 (-21.84%)
since 08/02/24
52-Week
0.3510 +172.79%
on 11/13/23
2.1050 -54.51%
on 03/25/24
+0.5725 (+148.70%)
since 11/03/23

Most Recent Stories

More News
Ocugen Clinical Showcase Highlighting Progress in Retinal Gene Therapy Clinical Trials in New York City on Tuesday, November 12, 2024

OCGN : 0.9575 (+0.86%)
Data and Safety Monitoring Board Approves Initiation of Phase 2 of OCU410ST GARDian Clinical Trial for Stargardt Disease

OCGN : 0.9575 (+0.86%)
Ocugen to Host Conference Call on Friday, November 8 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2024 Financial Results

OCGN : 0.9575 (+0.86%)
Ocugen to Participate in 2024 Maxim Healthcare Virtual Summit

OCGN : 0.9575 (+0.86%)
Ocugen, Inc. Announces Removal of Clinical Hold on Investigational New Drug Application for OCU200 Phase 1 Clinical Trial

OCGN : 0.9575 (+0.86%)
2 Penny Stocks That Wall Street Believes Can Soar Around 292% to 442%

Analysts believe these two penny stocks have outstanding long-term potential.

ATOS : 1.4100 (-0.70%)
OCGN : 0.9575 (+0.86%)
$SPX : 5,712.69 (-0.28%)
Ocugen (OCGN) Q2 2024 Earnings Call Transcript

OCGN earnings call for the period ending June 30, 2024.

OCGN : 0.9575 (+0.86%)
Ocugen: Q2 Earnings Snapshot

Ocugen: Q2 Earnings Snapshot

OCGN : 0.9575 (+0.86%)
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid

These two stocks could have vastly different long-term performances.

CRSP : 50.59 (-0.33%)
OCGN : 0.9575 (+0.86%)
1 Stock That More Than Doubled This Year That I Wouldn't Touch With a 10-Foot Pole

Don't jump on the bandwaggon.

OCGN : 0.9575 (+0.86%)

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 1.0535
2nd Resistance Point 1.0153
1st Resistance Point 0.9864
Last Price 0.9575
1st Support Level 0.9193
2nd Support Level 0.8811
3rd Support Level 0.8522

See More

52-Week High 2.1050
Fibonacci 61.8% 1.4350
Fibonacci 50% 1.2280
Fibonacci 38.2% 1.0210
Last Price 0.9575
52-Week Low 0.3510

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar